Results 121 to 130 of about 125,028 (162)
Some of the next articles are maybe not open access.
Annual Review of Medicine, 2005
The development of new anticoagulants is expanding the list of drugs that can be used to prevent and treat venous and arterial thrombosis. New parenteral anticoagulants have been developed to overcome the limitations of heparin and low-molecular-weight heparin, whereas novel orally active anticoagulants have been designed to provide more streamlined ...
Lori-Ann, Linkins, Jeffrey I, Weitz
openaire +2 more sources
The development of new anticoagulants is expanding the list of drugs that can be used to prevent and treat venous and arterial thrombosis. New parenteral anticoagulants have been developed to overcome the limitations of heparin and low-molecular-weight heparin, whereas novel orally active anticoagulants have been designed to provide more streamlined ...
Lori-Ann, Linkins, Jeffrey I, Weitz
openaire +2 more sources
Anticoagulant therapy with ancrod
Critical Reviews in Oncology/Hematology, 19935.7. 5.8 ......... . . Treatment of venous thromboembolism 5.1.1. Deep venous thrombosis 5.1.2. Pulmonaryembolus Prophylaxis of venous thromboembolism Other venous thrombotic disorders Treatment of arterial thromboembolism 5.4.
R L, Soutar, J S, Ginsberg
openaire +2 more sources
Pharmacogenetics and Anticoagulant Therapy
Journal of Thrombosis and Thrombolysis, 2003Warfarin and other coumarins are metabolized by the cytochrome P450 2C9 complex. Common single-nucleotide polymorphisms (SNPs) in this enzyme are associated with an exaggerated elevation in the INR during warfarin initiation and an increased risk of bleeding. These observations suggest that patients known to carry the putative SNPs should be started on
Brian F, Gage, Charles S, Eby
openaire +2 more sources
The Management of Anticoagulant Therapy
Postgraduate Medicine, 1960Safe, effective anticoagulant therapy requires observance of certain principles of management. The physician must be certain that an absolute contraindication to such therapy does not exist, must be familiar with the agents employed, and must know how to reverse their effects promptly.
P W, WILLIS, W W, COON, I F, DUFF
openaire +2 more sources
Anticoagulant therapy in practice
Orvosi Hetilap, 2012Atrial fibrillation is a risk factor for ischemic stroke. To prevent stroke oral anticoagulants can be administered. Old and new types of anticoagulants are available. Nowadays, old type, acenocumarol based anticoagulants are used preferentially in Hungary.
Gergely, Hofgárt +2 more
openaire +2 more sources
Anticoagulation Therapies in Children
Pediatric Clinics of North America, 2017Venous thromboembolism is occurring with increasing frequency in children resulting in the more widespread use of anticoagulation in pediatrics. Antithrombotic drugs in children can be divided into the standard and alternative agents. This review discusses standard and alternative anticoagulants.
openaire +2 more sources
ANTICOAGULANT THERAPY IN SURGERY
Journal of the American Medical Association, 1950More than twelve years have elapsed since purified heparin preparations became available for clinical use.1The introduction of the second anticoagulant, dicumarol,® followed in 1941,2and since then a wide application of these two drugs resulted in all fields of medicine.
openaire +2 more sources
Current Opinion in Hematology, 1996
Oral anticoagulant therapy is effective antithrombotic treatment for several indications. The results of prothrombin time monitoring should be reported as the International Normalized Ratio (INR). An INR of 2 to 3 is the recommended therapeutic range for all indications except for the prevention of systemic embolism in patients with mechanical heart ...
openaire +2 more sources
Oral anticoagulant therapy is effective antithrombotic treatment for several indications. The results of prothrombin time monitoring should be reported as the International Normalized Ratio (INR). An INR of 2 to 3 is the recommended therapeutic range for all indications except for the prevention of systemic embolism in patients with mechanical heart ...
openaire +2 more sources
Warfarin anticoagulant therapy
British Dental Journal, 1984B M, Bailey, A M, Fordyce
openaire +4 more sources